Product Description

BOC Sciences offers a classification of iridoid derivatives chemical products, which are all iridoid derivatives chemical products obtained by chemical processes (chemical production techniques when chemical methods are used to change the composition or structure of substances or to synthesize new substances). The cyclic enol ether terpenoids and cleaved iridoids, which are transformed from odorant dialdehyde in the plant world, are derivatives of iridoids, and in the plant body, they are all closely related substances formed by the biosynthesis of nornanol phosphate. They are monoterpene derivatives with cycloalkenyl ether bonds in the molecule. For example, the Dujuanoside element in the mountain mast has a significant bile-promoting and laxative effect.

Applications of Iridoid Derivatives

• Iridoid derivatives as antileishmanial drugs

Leishmaniasis is common in about 88 countries worldwide and is a disease that affects about 12 million people. Unfortunately, the various drugs used to treat leishmaniasis have side effects and resistance to these drugs has developed over the years. As a potential alternative, iridoid derivatives offer the candidacy to be considered as a new drug therapy.

• Iridoid derivatives as antiplasmodial agents

Iridoid derivatives exhibit significant inhibitory effects against Plasmodium falciparum.

• Iridoid derivatives as anti-inflammatory agents

Iridoid derivatives are used in the treatment of inflammatory diseases, toothache, anemia, fever, bronchitis, pain, swelling, blood disorders, cough and asthma.

• Iridoid derivatives used as antidiabetic agents

Iridoid derivatives are used in the treatment of diabetic nephropathy and also have anti-hyperglycemic, antioxidant and anti-aging properties, among others. In addition, iridoid derivatives not only lower blood glucose levels but also play a crucial role in the treatment of diabetic complications, encouragingly without any side effects on multiple targets.

• Iridoid derivatives as anticancer agents

Iridoid derivatives block tumor cells in the G0 /G1 phase by binding to tyrosine kinase phosphorylated ATP of the EGFR/HER2 receptor, whose phosphorylation is then inhibited by this compound.

• Xanthones
• Lignans
• Coumarins
• Other Quinones
• Sesquiterpene
• Iridoids